1. Home
  2. CDLR vs NEO Comparison

CDLR vs NEO Comparison

Compare CDLR & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cadeler AS

CDLR

Cadeler AS

HOLD

Current Price

$23.00

Market Cap

2.0B

Sector

N/A

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$15.90

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDLR
NEO
Founded
2008
2001
Country
Denmark
United States
Employees
N/A
N/A
Industry
Precision Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.1B
IPO Year
2023
2008

Fundamental Metrics

Financial Performance
Metric
CDLR
NEO
Price
$23.00
$15.90
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$13.38
AVG Volume (30 Days)
60.4K
3.0M
Earning Date
05-20-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$53.56
$10.63
Revenue Next Year
$32.79
$9.73
P/E Ratio
$7.39
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.37
$5.94
52 Week High
$30.01
$16.92

Technical Indicators

Market Signals
Indicator
CDLR
NEO
Relative Strength Index (RSI) 51.30 57.99
Support Level $20.81 $13.43
Resistance Level $23.79 N/A
Average True Range (ATR) 0.37 0.69
MACD 0.04 -0.01
Stochastic Oscillator 64.42 74.42

Price Performance

Historical Comparison
CDLR
NEO

About CDLR Cadeler AS

Cadeler AS is an offshore wind installation vessel contractor. It currently operates various offshore jack-up wind installation vessels, with new builds on order. The Group operates within the market for the transportation and installation of offshore wind turbine generators (WTGs) and their foundations. In addition to wind farm installation, its vessels can perform maintenance, decommissioning, and other general construction tasks within the offshore industry. Cadler's customer base consists of offshore wind farm developers, original equipment manufacturers, and various offshore contractors. Geographically, the Group generates maximum revenue from the United States and the rest from the United Kingdom, Taiwan, Germany, Denmark, Poland, and other regions.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: